Clearside Biomedical Inc.

0.80
0.00 (0.00%)
At close: Apr 22, 2025, 3:59 PM
0.79
-0.25%
After-hours: Apr 22, 2025, 07:55 PM EDT

Clearside Biomedical Statistics

Share Statistics

Clearside Biomedical has 77.28M shares outstanding. The number of shares has increased by 1.49% in one year.

Shares Outstanding 77.28M
Shares Change (YoY) 1.49%
Shares Change (QoQ) 0%
Owned by Institutions (%) 12.63%
Shares Floating 61.02M
Failed to Deliver (FTD) Shares 2.89K
FTD / Avg. Volume 1.37%

Short Selling Information

The latest short interest is 468.9K, so 0.62% of the outstanding shares have been sold short.

Short Interest 468.9K
Short % of Shares Out 0.62%
Short % of Float 0.66%
Short Ratio (days to cover) 2.61

Valuation Ratios

The PE ratio is -2.04 and the forward PE ratio is -1.48. Clearside Biomedical's PEG ratio is 0.18.

PE Ratio -2.04
Forward PE -1.48
PS Ratio 42.14
Forward PS 0.6
PB Ratio -1.8
P/FCF Ratio -2.84
PEG Ratio 0.18
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Clearside Biomedical.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.44, with a Debt / Equity ratio of -0.02.

Current Ratio 4.44
Quick Ratio 4.44
Debt / Equity -0.02
Debt / EBITDA -0.03
Debt / FCF -0.03
Interest Coverage -2.95

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $52K
Profits Per Employee $-1.07M
Employee Count 32
Asset Turnover 0.07
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -41.61% in the last 52 weeks. The beta is 2.04, so Clearside Biomedical's price volatility has been higher than the market average.

Beta 2.04
52-Week Price Change -41.61%
50-Day Moving Average 0.92
200-Day Moving Average 1.05
Relative Strength Index (RSI) 40.87
Average Volume (20 Days) 211.29K

Income Statement

In the last 12 months, Clearside Biomedical had revenue of 1.66M and earned -34.35M in profits. Earnings per share was -0.47.

Revenue 1.66M
Gross Profit 1.51M
Operating Income -28.88M
Net Income -34.35M
EBITDA -24.35M
EBIT -24.57M
Earnings Per Share (EPS) -0.47
Full Income Statement

Balance Sheet

The company has 20.02M in cash and 703K in debt, giving a net cash position of 19.32M.

Cash & Cash Equivalents 20.02M
Total Debt 703K
Net Cash 19.32M
Retained Earnings -355.27M
Total Assets 25.13M
Working Capital 16.48M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -24.7M and capital expenditures 0, giving a free cash flow of -24.7M.

Operating Cash Flow -24.7M
Capital Expenditures 0
Free Cash Flow -24.7M
FCF Per Share -0.33
Full Cash Flow Statement

Margins

Gross margin is 91.05%, with operating and profit margins of -1735.7% and -2064.42%.

Gross Margin 91.05%
Operating Margin -1735.7%
Pretax Margin -2064.42%
Profit Margin -2064.42%
EBITDA Margin -1463.16%
EBIT Margin -1735.7%
FCF Margin -1484.25%

Dividends & Yields

CLSD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for CLSD is $5, which is 525% higher than the current price. The consensus rating is "Buy".

Price Target $5
Price Target Difference 525%
Analyst Consensus Buy
Analyst Count 5
Stock Forecasts

Scores

Altman Z-Score -21.55
Piotroski F-Score 3